Publication | Open Access
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
45
Citations
27
References
2022
Year
These results indicated that NLRP3/IL-1β is involved in the pathogenesis of endometriosis and that NLRP3 inhibitors may be useful for suppressing OE and improving the function of ovaries with endometriosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1